Injective Eyes $8.62 Target as Smart Money Leans Long
Injective (INJ) is currently trading at $7.72, up nearly 2% in the last 24 hours. The price is holding steady above key moving averages, with the 50-day average at $6.22 and the 200-day average at $4.72. This suggests a strong upward trend rather than a short-term bounce. The broader Layer-1 and DeFi market conditions are favorable, with institutional activity picking up heading into Q4 2026.
The immediate resistance level for INJ is $7.84, with the next significant hurdle at $7.96. If these levels are breached, the upper Bollinger Band at $8.62 becomes a realistic target within 7-10 days. Support levels are identified at $7.52 and $7.31, with the latter being a critical line in the sand. A daily close below $7.31 would severely damage the bullish outlook.
From a technical perspective, the MACD histogram is near zero, indicating a potential consolidation phase before the next move. The Stochastic oscillator shows momentum divergence, favoring a continued upward trend. The upper Bollinger Band at $8.62 is a natural target if buying pressure continues. The average true range (ATR) of $0.56 per day suggests this level is within reach in the near term.
The market sentiment is divided, with retail traders net short at 52% while top traders are 58% net long. This divergence could amplify a breakout if $7.84 is surpassed, triggering a short squeeze. Funding rates remain neutral at 0.01%, indicating no overheated long positions.
The bullish case, with a 65% probability, envisions INJ breaking above $7.84 and targeting $8.62. If broader crypto sentiment remains strong, INJ could test $9.00, $9.50 within 30 days. The bearish scenario, at 35% probability, sees INJ failing to break $7.84 and retesting $7.52, with potential downside to $7.31 or even $6.80, $7.00.